A citation-based method for searching scientific literature

Robert V Farese, Mini P Sajan. Am J Physiol Endocrinol Metab 2010
Times Cited: 54







List of co-cited articles
395 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes.
Robert V Farese, Mini P Sajan, Hong Yang, Pengfei Li, Steven Mastorides, William R Gower, Sonali Nimal, Cheol Soo Choi, Sheene Kim, Gerald I Shulman,[...]. J Clin Invest 2007
128
38

PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity.
Michihiro Matsumoto, Wataru Ogawa, Kazunori Akimoto, Hiroshi Inoue, Kazuaki Miyake, Kensuke Furukawa, Yoshitake Hayashi, Haruhisa Iguchi, Yasushi Matsuki, Ryuji Hiramatsu,[...]. J Clin Invest 2003
140
33


The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity.
Mini P Sajan, Mary L Standaert, Sonali Nimal, Usha Varanasi, Tina Pastoor, Stephen Mastorides, Ursula Braun, Michael Leitges, Robert V Farese. J Lipid Res 2009
44
31


Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι.
Mini P Sajan, Sonali Nimal, Stephen Mastorides, Mildred Acevedo-Duncan, C Ronald Kahn, Alan P Fields, Ursula Braun, Michael Leitges, Robert V Farese. Metabolism 2012
27
44

Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta.
Cullen M Taniguchi, Tatsuya Kondo, Mini Sajan, Ji Luo, Roderick Bronson, Tomoichiro Asano, Robert Farese, Lewis C Cantley, C Ronald Kahn. Cell Metab 2006
212
20

Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Mary Beeson, Mini P Sajan, Michelle Dizon, Dmitry Grebenev, Joaquin Gomez-Daspet, Atsushi Miura, Yoshinori Kanoh, Jennifer Powe, Gautam Bandyopadhyay, Mary L Standaert,[...]. Diabetes 2003
137
18




The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis.
Shaodong Guo, Kyle D Copps, Xiaocheng Dong, Sunmin Park, Zhiyong Cheng, Alessandro Pocai, Luciano Rossetti, Mini Sajan, Robert V Farese, Morris F White. Mol Cell Biol 2009
103
16

Repletion of atypical protein kinase C following RNA interference-mediated depletion restores insulin-stimulated glucose transport.
Mini P Sajan, Jose Rivas, Pengfei Li, Mary L Standaert, Robert V Farese. J Biol Chem 2006
49
16

Protein kinase Czeta is a negative regulator of protein kinase B activity.
R P Doornbos, M Theelen, P C van der Hoeven, W J van Blitterswijk, A J Verkleij, P M van Bergen en Henegouwen. J Biol Chem 1999
118
14

The nuts and bolts of AGC protein kinases.
Laura R Pearce, David Komander, Dario R Alessi. Nat Rev Mol Cell Biol 2010
888
14


Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.
Ling He, Amin Sabet, Stephen Djedjos, Ryan Miller, Xiaojian Sun, Mehboob A Hussain, Sally Radovick, Fredric E Wondisford. Cell 2009
314
14

Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Michihiro Matsumoto, Alessandro Pocai, Luciano Rossetti, Ronald A Depinho, Domenico Accili. Cell Metab 2007
431
14

Critical nodes in signalling pathways: insights into insulin action.
Cullen M Taniguchi, Brice Emanuelli, C Ronald Kahn. Nat Rev Mol Cell Biol 2006
12

New insights into the integrated physiology of insulin action.
Yukari Kitamura, Domenico Accili. Rev Endocr Metab Disord 2004
21
33

Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome.
Guang Yang, Leylla Badeanlou, Jacek Bielawski, Amanda J Roberts, Yusuf A Hannun, Fahumiya Samad. Am J Physiol Endocrinol Metab 2009
220
12


Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity.
Mini P Sajan, Mildred E Acevedo-Duncan, Mary L Standaert, Robert A Ivey, Mackenzie Lee, Robert V Farese. Diabetes 2014
25
28

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
D D Sarbassov, David A Guertin, Siraj M Ali, David M Sabatini. Science 2005
11

Insulin sensitivity: modulation by nutrients and inflammation.
Simon Schenk, Maziyar Saberi, Jerrold M Olefsky. J Clin Invest 2008
790
11



Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins.
Y F Liu, K Paz, A Herschkovitz, A Alt, T Tennenbaum, S R Sampson, M Ohba, T Kuroki, D LeRoith, Y Zick. J Biol Chem 2001
156
9

Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic.
Kei Sakamoto, Geoffrey D Holman. Am J Physiol Endocrinol Metab 2008
304
9


Protein kinase C-lambda knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport.
Gautam Bandyopadhyay, Mary L Standaert, Mini P Sajan, Yoshinori Kanoh, Atsushi Miura, Uschi Braun, Friederike Kruse, Michael Leitges, Robert V Farese. Mol Endocrinol 2004
42
11



AKT/PKB signaling: navigating downstream.
Brendan D Manning, Lewis C Cantley. Cell 2007
9




Selective versus total insulin resistance: a pathogenic paradox.
Michael S Brown, Joseph L Goldstein. Cell Metab 2008
603
9

Lipid-induced insulin resistance: unravelling the mechanism.
Varman T Samuel, Kitt Falk Petersen, Gerald I Shulman. Lancet 2010
709
9


Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.
Varman T Samuel, Zhen-Xiang Liu, Amy Wang, Sara A Beddow, John G Geisler, Mario Kahn, Xian-man Zhang, Brett P Monia, Sanjay Bhanot, Gerald I Shulman. J Clin Invest 2007
355
9

Role of AMP-activated protein kinase in mechanism of metformin action.
G Zhou, R Myers, Y Li, Y Chen, X Shen, J Fenyk-Melody, M Wu, J Ventre, T Doebber, N Fujii,[...]. J Clin Invest 2001
9

Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
John R Ussher, Timothy R Koves, Virgilio J J Cadete, Liyan Zhang, Jagdip S Jaswal, Suzanne J Swyrd, David G Lopaschuk, Spencer D Proctor, Wendy Keung, Deborah M Muoio,[...]. Diabetes 2010
250
9

PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
Mini P Sajan, Robert A Ivey, Mackenzie Lee, Stephen Mastorides, Michael J Jurczak, Varman T Samuels, Gerald I Shulman, Ursula Braun, Michael Leitges, Robert V Farese. Mol Endocrinol 2014
9
55


Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1.
Klaus Moeschel, Alexander Beck, Cora Weigert, Reiner Lammers, Hubert Kalbacher, Wolfgang Voelter, Erwin D Schleicher, Hans-Ulrich Häring, Rainer Lehmann. J Biol Chem 2004
93
7



Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway.
M Leitges, L Sanz, P Martin, A Duran, U Braun, J F García, F Camacho, M T Diaz-Meco, P D Rennert, J Moscat. Mol Cell 2001
311
7

PKC-theta knockout mice are protected from fat-induced insulin resistance.
Jason K Kim, Jonathan J Fillmore, Mary Jean Sunshine, Bjoern Albrecht, Takamasa Higashimori, Dong-Wook Kim, Zhen-Xiang Liu, Timothy J Soos, Gary W Cline, William R O'Brien,[...]. J Clin Invest 2004
348
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.